Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT02191098
1:37:chronic_disease,39:63:chronic_disease,68:89:chronic_disease,
Symptomatic congestive heart failure, unstable angina pectoris, or Myocardial infarction within 6 months prior to screening
3
[ "Symptomatic", "congestive", "heart", "failure", ",", "unstable", "angina", "pectoris", ",", "or", "Myocardial", "infarction", "within", "6", "months", "prior", "to", "screening" ]
[ 2, 2, 2, 2, 0, 2, 2, 2, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02392572
63:78:cancer,82:95:cancer,118:127:treatment
For Arms A, B, C, D patients must have relapsed or refractory acute leukemias or high-risk MDS for which no standard therapies are anticipated to result in a durable remission
3
[ "For", "Arms", "A", ",", "B", ",", "C", ",", "D", "patients", "must", "have", "relapsed", "or", "refractory", "acute", "leukemias", "or", "high-risk", "MDS", "for", "which", "no", "standard", "therapies", "are", "anticipated", "to", "result", "in", "a", "durable", "remission" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 3, 3, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01880567
21:24:cancer,49:71:chronic_disease,108:119:chronic_disease,121:145:chronic_disease,149:170:chronic_disease,,,,250:265:chronic_disease,
Relapsed/refractory MCL: Clinically significant cardiovascular disease such as uncontrolled or symptomatic arrhythmias, congestive heart failure or myocardial infarction within 6 months at the time of consent or any class 3 (moderate) or 4 (severe) cardiac disease defined by the New York Heart Association classification
3
[ "Relapsed/refractory", "MCL", ":", "Clinically", "significant", "cardiovascular", "disease", "such", "as", "uncontrolled", "or", "symptomatic", "arrhythmias", ",", "congestive", "heart", "failure", "or", "myocardial", "infarction", "within", "6", "months", "at", "the", "time", "of", "consent", "or", "any", "class", "3", "(", "moderate", ")", "or", "4", "(", "severe", ")", "cardiac", "disease", "defined", "by", "the", "New", "York", "Heart", "Association", "classification" ]
[ 0, 3, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 2, 0, 2, 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02452268
13:28:treatment,37:43:cancer,50:65:treatment,58:65:treatment,70:85:cancer
Subjects on bisphosphonates for any cancer or on hormone therapy for prostate cancer may continue this therapy
3
[ "Subjects", "on", "bisphosphonates", "for", "any", "cancer", "or", "on", "hormone", "therapy", "for", "prostate", "cancer", "may", "continue", "this", "therapy" ]
[ 0, 0, 1, 0, 0, 3, 0, 0, 1, 1, 0, 3, 3, 0, 0, 0, 0 ]
NCT02349867
11:24:chronic_disease
Suspected malabsorption or obstruction
3
[ "Suspected", "malabsorption", "or", "obstruction" ]
[ 0, 2, 0, 0 ]
NCT02570984
,24:43:treatment,
More than one night of albuterol treatment (for symptoms) in the past two weeks
3
[ "More", "than", "one", "night", "of", "albuterol", "treatment", "(", "for", "symptoms", ")", "in", "the", "past", "two", "weeks" ]
[ 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01994382
9:18:treatment,31:56:treatment,58:77:treatment,79:101:treatment
Chronic treatment with strong CYP3A4 inhibitor/ inducer, acid reducing agent, Proton pump inhibitors
3
[ "Chronic", "treatment", "with", "strong", "CYP3A4", "inhibitor/", "inducer", ",", "acid", "reducing", "agent", ",", "Proton", "pump", "inhibitors" ]
[ 0, 1, 0, 0, 1, 1, 1, 0, 1, 1, 1, 0, 1, 1, 1 ]
NCT02774421
14:25:chronic_disease
uncontrolled arrhythmias
3
[ "uncontrolled", "arrhythmias" ]
[ 0, 2 ]
NCT02058095
29:32:chronic_disease,,
A total of 39 patients with PDD as defined by an ejection fraction of greater than 50%
3
[ "A", "total", "of", "39", "patients", "with", "PDD", "as", "defined", "by", "an", "ejection", "fraction", "of", "greater", "than", "50", "%" ]
[ 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02304458
,26:40:chronic_disease
Patients with >= grade 2 hypothyroidism due to history of autoimmunity
3
[ "Patients", "with", ">", "=", "grade", "2", "hypothyroidism", "due", "to", "history", "of", "autoimmunity" ]
[ 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0 ]
NCT02807272
1:22:chronic_disease
myocardial infarction within the prior year
3
[ "myocardial", "infarction", "within", "the", "prior", "year" ]
[ 2, 2, 0, 0, 0, 0 ]
NCT01445821
4:18:treatment,,,,100:122:chronic_disease,126:169:chronic_disease
On echocardiogram tricuspid annular peak systolic excursion (TAPSE) ≤ 1.8 cm or, grade II or worse Right Ventricular (RV) or Left Ventricular (LV) diastolic dysfunction
3
[ "On", "echocardiogram", "tricuspid", "annular", "peak", "systolic", "excursion", "(", "TAPSE", ")", "≤", "1.8", "cm", "or", ",", "grade", "II", "or", "worse", "Right", "Ventricular", "(", "RV", ")", "or", "Left", "Ventricular", "(", "LV", ")", "diastolic", "dysfunction" ]
[ 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 2, 2, 2, 2, 2, 0, 0 ]
NCT02772562
23:27:allergy_name,29:41:allergy_name,43:69:allergy_name
History of allergy to eggs, egg products, aminoglycoside antibiotics
3
[ "History", "of", "allergy", "to", "eggs", ",", "egg", "products", ",", "aminoglycoside", "antibiotics" ]
[ 0, 0, 0, 0, 4, 0, 4, 4, 0, 4, 4 ]
NCT02389309
32:64:allergy_name
History of hypersensitivity to any component of the formulation
3
[ "History", "of", "hypersensitivity", "to", "any", "component", "of", "the", "formulation" ]
[ 0, 0, 0, 0, 4, 4, 4, 4, 4 ]
NCT02132598
,,,,218:228:treatment
For this reason women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for 4 months after the last dose of study drug, even if oral contraceptives are used
3
[ "For", "this", "reason", "women", "of", "child-bearing", "potential", "and", "men", "must", "agree", "to", "use", "adequate", "contraception", "(", "hormonal", "or", "barrier", "method", "of", "birth", "control", ";", "abstinence", ")", "prior", "to", "study", "entry", "and", "for", "4", "months", "after", "the", "last", "dose", "of", "study", "drug", ",", "even", "if", "oral", "contraceptives", "are", "used" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01795573
73:82:treatment,217:249:treatment,267:294:treatment,385:405:treatment
HL: No clinical evidence of disease or disease-related symptoms; A post-treatment residual mass of any size is permitted as long as it is PET negative; Spleen and liver must be non-palpable and without nodules; If a pre-treatment bone marrow biopsy was positive, an adequate bone marrow biopsy from the same site must be cleared of infiltrate; if this is indeterminate by morphology, immunohistochemistry should be negative
3
[ "HL", ":", "No", "clinical", "evidence", "of", "disease", "or", "disease-related", "symptoms", ";", "A", "post-treatment", "residual", "mass", "of", "any", "size", "is", "permitted", "as", "long", "as", "it", "is", "PET", "negative", ";", "Spleen", "and", "liver", "must", "be", "non-palpable", "and", "without", "nodules", ";", "If", "a", "pre-treatment", "bone", "marrow", "biopsy", "was", "positive", ",", "an", "adequate", "bone", "marrow", "biopsy", "from", "the", "same", "site", "must", "be", "cleared", "of", "infiltrate", ";", "if", "this", "is", "indeterminate", "by", "morphology", ",", "immunohistochemistry", "should", "be", "negative" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT02522715
12:19:chronic_disease,110:122:chronic_disease,124:130:chronic_disease,,153:173:cancer,175:191:cancer,193:207:chronic_disease
history of seizure or any condition that may predispose to seizure including, but not limited to, underlying brain injury, stroke in the past 6 months, primary brain tumors, brain metastases, prior seizures
3
[ "history", "of", "seizure", "or", "any", "condition", "that", "may", "predispose", "to", "seizure", "including", ",", "but", "not", "limited", "to", ",", "underlying", "brain", "injury", ",", "stroke", "in", "the", "past", "6", "months", ",", "primary", "brain", "tumors", ",", "brain", "metastases", ",", "prior", "seizures" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 2, 0, 0, 0, 0, 0, 0, 3, 3, 3, 0, 0, 0, 0, 2, 2 ]
NCT02473536
23:35:treatment,,
Subjects who have had radiotherapy to a target within 3 cm of the IVC tumor thrombus
3
[ "Subjects", "who", "have", "had", "radiotherapy", "to", "a", "target", "within", "3", "cm", "of", "the", "IVC", "tumor", "thrombus" ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02930018
8:16:allergy_name,57:75:allergy_name,87:112:treatment,235:262:chronic_disease,300:310:treatment
Severe contrast allergy or absolute contraindication to iodinated contrast preventing endovascular intervention, including any contraindications listed in the prescribing information approved by local authorities (e.g., patients with decompensated heart failure as a contraindication for the use of VISIPAQUE™ 270 in Germany
3
[ "Severe", "contrast", "allergy", "or", "absolute", "contraindication", "to", "iodinated", "contrast", "preventing", "endovascular", "intervention", ",", "including", "any", "contraindications", "listed", "in", "the", "prescribing", "information", "approved", "by", "local", "authorities", "(", "e.g.", ",", "patients", "with", "decompensated", "heart", "failure", "as", "a", "contraindication", "for", "the", "use", "of", "VISIPAQUE™", "270", "in", "Germany" ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
NCT02035085
1:17:treatment
Metallic implant
3
[ "Metallic", "implant" ]
[ 1, 1 ]
NCT02412540
1:16:chronic_disease
hemochromatosis
3
[ "hemochromatosis" ]
[ 2 ]
NCT00391170
32:45:allergy_name
Documented hypersensitivity to dexamethasone
3
[ "Documented", "hypersensitivity", "to", "dexamethasone" ]
[ 0, 0, 0, 4 ]
NCT02012296
1:20:chronic_disease,24:48:treatment,49:81:treatment
Progressive disease on computed tomography (CT)/magnetic resonance imaging (MRI) according to Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria
3
[ "Progressive", "disease", "on", "computed", "tomography", "(", "CT", ")", "/magnetic", "resonance", "imaging", "(", "MRI", ")", "according", "to", "Response", "Evaluation", "Criteria", "in", "Solid", "Tumors", "(", "RECIST", ")", "1.1", "criteria" ]
[ 2, 2, 0, 1, 1, 1, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02191488
12:25:chronic_disease,
History of liver disease within the last 12 months
3
[ "History", "of", "liver", "disease", "within", "the", "last", "12", "months" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0 ]
NCT03023696
56:75:chronic_disease,85:98:chronic_disease,117:149:treatment,,,238:259:treatment,264:284:treatment
Cleveland Clinic patients who have been diagnosed with cervical myelopathy, without radiculopathy, and will undergo posterior cervical decompression involving the C4-C5 interspace between 2016 and 2018. This includes patients undergoing cervical laminoplasty and cervical laminectomy and fusion
3
[ "Cleveland", "Clinic", "patients", "who", "have", "been", "diagnosed", "with", "cervical", "myelopathy", ",", "without", "radiculopathy", ",", "and", "will", "undergo", "posterior", "cervical", "decompression", "involving", "the", "C4-C5", "interspace", "between", "2016", "and", "2018", ".", "This", "includes", "patients", "undergoing", "cervical", "laminoplasty", "and", "cervical", "laminectomy", "and", "fusion" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 2, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02412540
23:45:treatment,63:89:treatment,,128:140:treatment
Current enrollment in another clinical trial or receipt of an investigational study drug within 6 months prior to the baseline liver biopsy
3
[ "Current", "enrollment", "in", "another", "clinical", "trial", "or", "receipt", "of", "an", "investigational", "study", "drug", "within", "6", "months", "prior", "to", "the", "baseline", "liver", "biopsy" ]
[ 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02387905
56:59:treatment
Patients unable to undergo magnetic resonance imaging (MRI) of the spine
3
[ "Patients", "unable", "to", "undergo", "magnetic", "resonance", "imaging", "(", "MRI", ")", "of", "the", "spine" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0 ]
NCT02687906
55:66:treatment
subjects receiving peri-operative prophylactic use of antibiotics
3
[ "subjects", "receiving", "peri-operative", "prophylactic", "use", "of", "antibiotics" ]
[ 0, 0, 0, 0, 0, 0, 1 ]
NCT02981082
,13:31:chronic_disease
ACR defined systemic sclerosis
3
[ "ACR", "defined", "systemic", "sclerosis" ]
[ 0, 0, 2, 2 ]
NCT02301663
1:9:chronic_disease
Diabetes
3
[ "Diabetes" ]
[ 2 ]
NCT02553642
28:52:treatment,
Patients may have received prior focal radiotherapy for palliation of an isolated site of disease, which must be completed at least 14 days prior to day 1 of the study
3
[ "Patients", "may", "have", "received", "prior", "focal", "radiotherapy", "for", "palliation", "of", "an", "isolated", "site", "of", "disease", ",", "which", "must", "be", "completed", "at", "least", "14", "days", "prior", "to", "day", "1", "of", "the", "study" ]
[ 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01220583
1:16:chronic_disease,24:48:chronic_disease,59:74:treatment,
Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months
3
[ "Unstable", "angina", "and/or", "congestive", "heart", "failure", "requiring", "hospitalization", "within", "the", "last", "6", "months" ]
[ 2, 2, 0, 2, 2, 2, 0, 1, 0, 0, 0, 0, 0 ]
NCT02033486
16:39:treatment
presenting for breast cancer treatment
3
[ "presenting", "for", "breast", "cancer", "treatment" ]
[ 0, 0, 1, 1, 1 ]
NCT02746458
1:11:treatment
skin graft
3
[ "skin", "graft" ]
[ 1, 1 ]
NCT02923011
56:71:cancer
Patients must have medically uncontrolled pain from an osteoid osteoma, as defined by pain, which, in the view of the referring orthopedic oncologist significantly interferes with that patient's activities of daily living
3
[ "Patients", "must", "have", "medically", "uncontrolled", "pain", "from", "an", "osteoid", "osteoma", ",", "as", "defined", "by", "pain", ",", "which", ",", "in", "the", "view", "of", "the", "referring", "orthopedic", "oncologist", "significantly", "interferes", "with", "that", "patient", "'s", "activities", "of", "daily", "living" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02101944
,,30:41:treatment
Platelet count >= 75,000 and transfusion independent
3
[ "Platelet", "count", ">", "=", "75,000", "and", "transfusion", "independent" ]
[ 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT01893307
1:20:chronic_disease
hematologic disease
3
[ "hematologic", "disease" ]
[ 2, 2 ]
NCT02915744
24:42:treatment
Concomitant use of any anticancer therapy or use of any investigational agent(s)
3
[ "Concomitant", "use", "of", "any", "anticancer", "therapy", "or", "use", "of", "any", "investigational", "agent", "(", "s", ")" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00969332
8:29:chronic_disease
recent myocardial infarction
3
[ "recent", "myocardial", "infarction" ]
[ 0, 2, 2 ]
NCT02234557
44:48:chronic_disease,76:95:chronic_disease,100:113:chronic_disease
Children must meet diagnostic criteria for ADHD on the Kiddie Schedule for Affective Disorders and Schizophrenia
3
[ "Children", "must", "meet", "diagnostic", "criteria", "for", "ADHD", "on", "the", "Kiddie", "Schedule", "for", "Affective", "Disorders", "and", "Schizophrenia" ]
[ 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 2, 2, 0, 2 ]
NCT03109041
17:35:treatment
Patient has had prior chemotherapy
3
[ "Patient", "has", "had", "prior", "chemotherapy" ]
[ 0, 0, 0, 1, 1 ]
NCT02643381
55:64:treatment
Any patient who has been previously randomized in the EvK Trial
3
[ "Any", "patient", "who", "has", "been", "previously", "randomized", "in", "the", "EvK", "Trial" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02188121
1:37:treatment
Concomitant psychotropic medications will be allowed
3
[ "Concomitant", "psychotropic", "medications", "will", "be", "allowed" ]
[ 1, 1, 1, 0, 0, 0 ]
NCT02665338
1:38:chronic_disease
Post-traumatic Stress disorder (PTSD)
3
[ "Post-traumatic", "Stress", "disorder", "(", "PTSD", ")" ]
[ 2, 2, 2, 2, 0, 0 ]
NCT02323880
1:24:treatment
Concomitant medications
3
[ "Concomitant", "medications" ]
[ 1, 1 ]
NCT01101451
29:36:chronic_disease
Patients with postoperative fistula
3
[ "Patients", "with", "postoperative", "fistula" ]
[ 0, 0, 0, 2 ]
NCT03059888
82:87:chronic_disease,89:96:chronic_disease,98:109:chronic_disease,111:127:chronic_disease,129:138:chronic_disease,140:147:chronic_disease,149:159:chronic_disease,163:179:chronic_disease
Subject has the presence at screening of any severe, progressive or uncontrolled renal, hepatic, hematologic, gastrointestinal, pulmonary, cardiac, neurologic or cerebral disease, whether or not related to MG that, in the opinion of the Investigator, might place the subject at unacceptable risk for participation in the study
3
[ "Subject", "has", "the", "presence", "at", "screening", "of", "any", "severe", ",", "progressive", "or", "uncontrolled", "renal", ",", "hepatic", ",", "hematologic", ",", "gastrointestinal", ",", "pulmonary", ",", "cardiac", ",", "neurologic", "or", "cerebral", "disease", ",", "whether", "or", "not", "related", "to", "MG", "that", ",", "in", "the", "opinion", "of", "the", "Investigator", ",", "might", "place", "the", "subject", "at", "unacceptable", "risk", "for", "participation", "in", "the", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 0, 2, 0, 2, 0, 2, 0, 2, 0, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03185208
14:39:chronic_disease
Diagnosis of Mild Cognitive Impairment
3
[ "Diagnosis", "of", "Mild", "Cognitive", "Impairment" ]
[ 0, 0, 2, 2, 2 ]
NCT00065676
1:20:chronic_disease
renal insufficiency
3
[ "renal", "insufficiency" ]
[ 2, 2 ]
NCT02498301
23:34:treatment,
Subject's duration of prophylaxis will be least 2 weeks
3
[ "Subject", "'s", "duration", "of", "prophylaxis", "will", "be", "least", "2", "weeks" ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02436070
1:27:chronic_disease
Inflammatory bowel disease
3
[ "Inflammatory", "bowel", "disease" ]
[ 2, 2, 2 ]
NCT02563678
,32:48:treatment,52:75:treatment,79:97:treatment,115:127:treatment
Use in the past 30 days of any over-the-counter or prescription medication or dietary supplement beyond a general multivitamin
3
[ "Use", "in", "the", "past", "30", "days", "of", "any", "over-the-counter", "or", "prescription", "medication", "or", "dietary", "supplement", "beyond", "a", "general", "multivitamin" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 1, 1, 0, 0, 0, 1 ]
NCT01868386
12:25:treatment
have had a prostatectomy
3
[ "have", "had", "a", "prostatectomy" ]
[ 0, 0, 0, 1 ]
NCT02259504
21:66:treatment
Intended or planned aneurysm treatment by parent vessel occlusion
3
[ "Intended", "or", "planned", "aneurysm", "treatment", "by", "parent", "vessel", "occlusion" ]
[ 0, 0, 0, 1, 1, 1, 1, 1, 1 ]
NCT01585402
22:32:treatment
Known sensitivity to etidronate
3
[ "Known", "sensitivity", "to", "etidronate" ]
[ 0, 0, 0, 1 ]
NCT02816736
1:24:chronic_disease,,54:80:treatment,107:126:chronic_disease
Acute coronary syndrome within 4 weeks as defined by electrocardiographic (ECG) changes and biomarkers of myocardial necrosis (e.g. troponin) in an appropriate clinical setting (chest discomfort or anginal equivalent)
3
[ "Acute", "coronary", "syndrome", "within", "4", "weeks", "as", "defined", "by", "electrocardiographic", "(", "ECG", ")", "changes", "and", "biomarkers", "of", "myocardial", "necrosis", "(", "e.g", ".", "troponin", ")", "in", "an", "appropriate", "clinical", "setting", "(", "chest", "discomfort", "or", "anginal", "equivalent", ")" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02995733
12:15:treatment
Prescribed ICS as daily maintenance therapy
3
[ "Prescribed", "ICS", "as", "daily", "maintenance", "therapy" ]
[ 0, 1, 0, 0, 0, 0 ]
NCT00358657
15:31:chronic_disease,79:91:treatment,107:125:treatment,
Patients with fungal pneumonia with radiological progression after receipt of amphotericin formulation or mold-active azoles for greater than 1 month
3
[ "Patients", "with", "fungal", "pneumonia", "with", "radiological", "progression", "after", "receipt", "of", "amphotericin", "formulation", "or", "mold-active", "azoles", "for", "greater", "than", "1", "month" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT02624258
1:3:chronic_disease
HL with biopsy-proven relapse
3
[ "HL", "with", "biopsy-proven", "relapse" ]
[ 2, 0, 0, 0 ]
NCT03150511
9:27:chronic_disease
Certain pituitary problems
3
[ "Certain", "pituitary", "problems" ]
[ 0, 2, 2 ]
NCT02504489
19:26:treatment
Modification of a regimen to manage toxicity with a different drug does not constitute a new regimen
3
[ "Modification", "of", "a", "regimen", "to", "manage", "toxicity", "with", "a", "different", "drug", "does", "not", "constitute", "a", "new", "regimen" ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02394028
5:37:treatment,
Any prior treatment with ustekinumab within 14 weeks prior to randomization
3
[ "Any", "prior", "treatment", "with", "ustekinumab", "within", "14", "weeks", "prior", "to", "randomization" ]
[ 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02778867
6:10:treatment
on a 6FED
3
[ "on", "a", "6FED" ]
[ 0, 0, 1 ]
NCT02053792
38:51:treatment,
Life-threatening bleeding episode or major surgery during the 3 months prior to substudy entry
3
[ "Life-threatening", "bleeding", "episode", "or", "major", "surgery", "during", "the", "3", "months", "prior", "to", "substudy", "entry" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02471833
16:51:treatment
Current use of renin-angiotensin acting medication
3
[ "Current", "use", "of", "renin-angiotensin", "acting", "medication" ]
[ 0, 0, 0, 1, 1, 1 ]
NCT01697293
5:10:cancer,84:99:treatment,101:148:treatment
the tumor must be human epidermal growth factor receptor 2 (Her2)/neu negative (by DAKO HercepTest, fluorescence based in situ hybridization [FISH], or other approved assay)
3
[ "the", "tumor", "must", "be", "human", "epidermal", "growth", "factor", "receptor", "2", "(", "Her2", ")", "/neu", "negative", "(", "by", "DAKO", "HercepTest", ",", "fluorescence", "based", "in", "situ", "hybridization", "[", "FISH", "]", ",", "or", "other", "approved", "assay", ")" ]
[ 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01686373
23:30:chronic_disease
Patients must have an aphasia diagnosis as confirmed by the Western Aphasia Battery-Revised
3
[ "Patients", "must", "have", "an", "aphasia", "diagnosis", "as", "confirmed", "by", "the", "Western", "Aphasia", "Battery-Revised" ]
[ 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01568918
1:40:treatment
Cervical Anterior Discectomy and Fusion
3
[ "Cervical", "Anterior", "Discectomy", "and", "Fusion" ]
[ 1, 1, 1, 1, 1 ]
NCT01625923
5:18:chronic_disease
Has gastroparesis at screening (gastric half-time of emptying > upper limit of normal as determined by wireless motility capsule)
3
[ "Has", "gastroparesis", "at", "screening", "(", "gastric", "half-time", "of", "emptying", ">", "upper", "limit", "of", "normal", "as", "determined", "by", "wireless", "motility", "capsule", ")" ]
[ 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02209545
1:21:treatment
abdominal myomectomy
3
[ "abdominal", "myomectomy" ]
[ 1, 1 ]
NCT02115685
1:25:chronic_disease
heterotopic ossification
3
[ "heterotopic", "ossification" ]
[ 2, 2 ]
NCT02405078
156:159:treatment,182:193:chronic_disease,203:224:chronic_disease
Any condition that, in the opinion of the investigator, would interfere with the interpretation of study results or subject safety including non-malignant FDG avid diseases such as sarcoidosis or other granulomatous disease
3
[ "Any", "condition", "that", ",", "in", "the", "opinion", "of", "the", "investigator", ",", "would", "interfere", "with", "the", "interpretation", "of", "study", "results", "or", "subject", "safety", "including", "non-malignant", "FDG", "avid", "diseases", "such", "as", "sarcoidosis", "or", "other", "granulomatous", "disease" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 2, 2 ]
NCT02253316
1:25:chronic_disease
unstable angina pectoris
3
[ "unstable", "angina", "pectoris" ]
[ 2, 2, 2 ]
NCT03137758
8:25:treatment,30:45:cancer,,68:77:treatment
use of opiate analgesics for prostate cancer pain within 4 week of treatment start
3
[ "use", "of", "opiate", "analgesics", "for", "prostate", "cancer", "pain", "within", "4", "week", "of", "treatment", "start" ]
[ 0, 0, 1, 1, 0, 3, 3, 0, 0, 0, 0, 0, 1, 0 ]
NCT02549833
62:66:chronic_disease,68:86:chronic_disease,101:109:chronic_disease,111:124:chronic_disease
Any conditions that could potentially alter immune function (AIDS, multiple sclerosis, uncontrolled diabetes, renal failure)
3
[ "Any", "conditions", "that", "could", "potentially", "alter", "immune", "function", "(", "AIDS", ",", "multiple", "sclerosis", ",", "uncontrolled", "diabetes", ",", "renal", "failure", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 2, 0, 0, 2, 0, 2, 2, 0 ]
NCT02579044
16:29:treatment
ho may require major surgery during the course of the study
3
[ "ho", "may", "require", "major", "surgery", "during", "the", "course", "of", "the", "study" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02501096
,,114:124:treatment
Must be on a stable dose of the same oral hormonal contraceptive product for at least 4 weeks before dosing with study drug and for the duration of the study
3
[ "Must", "be", "on", "a", "stable", "dose", "of", "the", "same", "oral", "hormonal", "contraceptive", "product", "for", "at", "least", "4", "weeks", "before", "dosing", "with", "study", "drug", "and", "for", "the", "duration", "of", "the", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT01943851
,87:102:treatment,93:102:treatment,189:198:treatment
Female subjects who are lactating must discontinue nursing prior to the first dose of study treatment and must refrain from nursing throughout the treatment period and for 5 half-lives of GSK525762
3
[ "Female", "subjects", "who", "are", "lactating", "must", "discontinue", "nursing", "prior", "to", "the", "first", "dose", "of", "study", "treatment", "and", "must", "refrain", "from", "nursing", "throughout", "the", "treatment", "period", "and", "for", "5", "half-lives", "of", "GSK525762" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02519452
1:30:cancer,,,,
immunoglobulin (Ig) G myeloma (serum monoclonal paraprotein [M-protein] level >=1.0 gram/deciliter [g/dL] or urine M-protein level greater than or equal to (>=) 200 milligram[mg]/24 hours[hrs]
3
[ "immunoglobulin", "(", "Ig", ")", "G", "myeloma", "(", "serum", "monoclonal", "paraprotein", "[", "M-protein", "]", "level", ">", "=1.0", "gram/deciliter", "[", "g/dL", "]", "or", "urine", "M-protein", "level", "greater", "than", "or", "equal", "to", "(", ">", "=", ")", "200", "milligram", "[", "mg", "]", "/24", "hours", "[", "hrs", "]" ]
[ 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02088554
1:13:treatment
LAA ligation
3
[ "LAA", "ligation" ]
[ 1, 1 ]
NCT02249520
26:36:treatment
Any contraindications to MR imaging
3
[ "Any", "contraindications", "to", "MR", "imaging" ]
[ 0, 0, 0, 1, 1 ]
NCT01562626
17:28:treatment,36:53:treatment,64:83:treatment
Currently using antibiotics and/or anti fungal agent (however, topical antibiotics are permitted)
3
[ "Currently", "using", "antibiotics", "and/or", "anti", "fungal", "agent", "(", "however", ",", "topical", "antibiotics", "are", "permitted", ")" ]
[ 0, 0, 1, 0, 1, 1, 1, 0, 0, 0, 1, 1, 0, 0, 0 ]
NCT02043548
30:38:treatment,45:57:treatment,59:71:treatment,73:83:treatment,85:106:treatment
8 week washout for any other IS agent (e.g. azathioprine, cyclosporine, tacrolimus, mycophenolate mofetil)
3
[ "8", "week", "washout", "for", "any", "other", "IS", "agent", "(", "e.g", ".", "azathioprine", ",", "cyclosporine", ",", "tacrolimus", ",", "mycophenolate", "mofetil", ")" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 0, 1, 0, 1, 0, 1, 1, 0 ]
NCT01037790
47:59:cancer
The subject has disease that is assessable by tumor marker, physical, or radiologic means
3
[ "The", "subject", "has", "disease", "that", "is", "assessable", "by", "tumor", "marker", ",", "physical", ",", "or", "radiologic", "means" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0 ]
NCT03135990
17:39:treatment,,,
Participants on psychiatric medication must be on a stable dose for at least 2 months prior to study participation and remain symptomatic to the level identified for study inclusion (Anxiety Disorders Interview Schedule-5 less than or equal to 4). Family agrees to refrain from med changes over the course of the study if at all possible
3
[ "Participants", "on", "psychiatric", "medication", "must", "be", "on", "a", "stable", "dose", "for", "at", "least", "2", "months", "prior", "to", "study", "participation", "and", "remain", "symptomatic", "to", "the", "level", "identified", "for", "study", "inclusion", "(", "Anxiety", "Disorders", "Interview", "Schedule-5", "less", "than", "or", "equal", "to", "4", ")", ".", "Family", "agrees", "to", "refrain", "from", "med", "changes", "over", "the", "course", "of", "the", "study", "if", "at", "all", "possible" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01898793
1:12:treatment,14:26:treatment,30:39:treatment,97:106:treatment
CNS therapy (chemotherapy or radiation) should continue as medically indicated during the study treatment
3
[ "CNS", "therapy", "(", "chemotherapy", "or", "radiation", ")", "should", "continue", "as", "medically", "indicated", "during", "the", "study", "treatment" ]
[ 1, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02278315
1:20:chronic_disease
Progressive disease
3
[ "Progressive", "disease" ]
[ 2, 2 ]
NCT01876511
28:45:cancer
Patients with MSI negative colorectal cancer
3
[ "Patients", "with", "MSI", "negative", "colorectal", "cancer" ]
[ 0, 0, 0, 0, 3, 3 ]
NCT02304458
1:28:treatment,36:57:treatment,59:68:treatment,,132:159:treatment
Radiopharmaceutical therapy (e.g., radiolabeled antibody, 131I-MIBG): >= 42 days must have elapsed since systemically administered radiopharmaceutical therapy
3
[ "Radiopharmaceutical", "therapy", "(", "e.g.", ",", "radiolabeled", "antibody", ",", "131I-MIBG", ")", ":", ">", "=", "42", "days", "must", "have", "elapsed", "since", "systemically", "administered", "radiopharmaceutical", "therapy" ]
[ 1, 1, 0, 0, 0, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT01795313
32:54:chronic_disease
must not have a history of any immune system disorder or laboratory abnormality or any condition that could potentially alter immune function
3
[ "must", "not", "have", "a", "history", "of", "any", "immune", "system", "disorder", "or", "laboratory", "abnormality", "or", "any", "condition", "that", "could", "potentially", "alter", "immune", "function" ]
[ 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03085485
14:22:chronic_disease
Uncontrolled Diabetes
3
[ "Uncontrolled", "Diabetes" ]
[ 0, 2 ]
NCT02243813
19:39:treatment,41:50:treatment,63:74:treatment,
Agree not to take sildenafil (Viagra®), tadalafil, or similar medications within 72 hours of each drug administration
3
[ "Agree", "not", "to", "take", "sildenafil", "(", "Viagra®", ")", ",", "tadalafil", ",", "or", "similar", "medications", "within", "72", "hours", "of", "each", "drug", "administration" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02106598
,,,53:66:chronic_disease
New York Heart Association Classification III or IV heart disease
3
[ "New", "York", "Heart", "Association", "Classification", "III", "or", "IV", "heart", "disease" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02955394
16:29:treatment
Planned to get local surgery
3
[ "Planned", "to", "get", "local", "surgery" ]
[ 0, 0, 0, 1, 1 ]
NCT03137121
28:34:treatment
Not have concurrent use of ethyol
3
[ "Not", "have", "concurrent", "use", "of", "ethyol" ]
[ 0, 0, 0, 0, 0, 1 ]
NCT02369458
23:29:treatment,31:35:treatment,37:46:treatment,51:57:treatment
Progression following platin, 5-FU, cetuximab and taxane given for incurable disease
3
[ "Progression", "following", "platin", ",", "5-FU", ",", "cetuximab", "and", "taxane", "given", "for", "incurable", "disease" ]
[ 0, 0, 1, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0 ]
NCT02050113
1:27:treatment
Previous abdominal surgery
3
[ "Previous", "abdominal", "surgery" ]
[ 1, 1, 1 ]
NCT02922569
28:97:treatment
Participants enrolled in a concurrent clinical trial involving an investigational pharmaceutical
3
[ "Participants", "enrolled", "in", "a", "concurrent", "clinical", "trial", "involving", "an", "investigational", "pharmaceutical" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1 ]
NCT03027388
14:34:chronic_disease,77:93:chronic_disease,107:131:chronic_disease,133:158:chronic_disease,159:177:chronic_disease
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia
3
[ "Uncontrolled", "intercurrent", "illness", "including", ",", "but", "not", "limited", "to", ",", "ongoing", "or", "active", "infection", ",", "symptomatic", "congestive", "heart", "failure", ",", "unstable", "angina", "pectoris", ",", "cardiac", "arrhythmia" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 2, 2, 2, 0, 2, 2, 2, 0, 2, 2 ]
NCT03028831
1:14:chronic_disease
malabsorption
3
[ "malabsorption" ]
[ 2 ]